276 related articles for article (PubMed ID: 21317461)
1. Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.
Taraboletti G; Rusnati M; Ragona L; Colombo G
Oncotarget; 2010 Nov; 1(7):662-673. PubMed ID: 21317461
[TBL] [Abstract][Full Text] [Related]
2. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.
Colombo G; Margosio B; Ragona L; Neves M; Bonifacio S; Annis DS; Stravalaci M; Tomaselli S; Giavazzi R; Rusnati M; Presta M; Zetta L; Mosher DF; Ribatti D; Gobbi M; Taraboletti G
J Biol Chem; 2010 Mar; 285(12):8733-42. PubMed ID: 20056600
[TBL] [Abstract][Full Text] [Related]
3. Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.
Chan LY; Craik DJ; Daly NL
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26464514
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tumor angiogenesis by thrombospondin-1.
Ren B; Yee KO; Lawler J; Khosravi-Far R
Biochim Biophys Acta; 2006 Apr; 1765(2):178-88. PubMed ID: 16406676
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
Lawler J
J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665
[TBL] [Abstract][Full Text] [Related]
8. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
Rege TA; Fears CY; Gladson CL
Neuro Oncol; 2005 Apr; 7(2):106-21. PubMed ID: 15831230
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondins as anti-angiogenic therapeutic agents.
Vailhé B; Feige JJ
Curr Pharm Des; 2003; 9(7):583-8. PubMed ID: 12570805
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
Lawler PR; Lawler J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
Punekar S; Zak S; Kalter VG; Dobransky L; Punekar I; Lawler JW; Gutierrez LS
Pathobiology; 2008; 75(1):9-21. PubMed ID: 18334835
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the functions of endogenous angiogenesis inhibitors.
Grant MA; Kalluri R
Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-based antiangiogenic therapy.
Zhang X; Lawler J
Microvasc Res; 2007; 74(2-3):90-9. PubMed ID: 17559888
[TBL] [Abstract][Full Text] [Related]
15. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondins in cancer.
Kazerounian S; Yee KO; Lawler J
Cell Mol Life Sci; 2008 Mar; 65(5):700-12. PubMed ID: 18193162
[TBL] [Abstract][Full Text] [Related]
17. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of endogenous angiogenesis inhibitors: a mechanism of action of metronomic chemotherapy.
Ng SS; Figg WD
Cancer Biol Ther; 2004 Dec; 3(12):1212-3. PubMed ID: 15662130
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.
Margosio B; Marchetti D; Vergani V; Giavazzi R; Rusnati M; Presta M; Taraboletti G
Blood; 2003 Dec; 102(13):4399-406. PubMed ID: 12947001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
